Study of genetic variants of MEFV gene in patients suffering from 2019-nCoV infection and it's comparison with general population by صالح زاده, فرهاد & شهبازفر, احسان
  
 
Abstract: 
 
Background and objective: In early 2020, an outbreak of pneumonia caused by a novel 
coronavirus became pandemic. This study evaluates the potential immune-genetically role 
of MEFV gene mutations in COVID 19 patients. 
Methods: Fifty COVID 19 PCR positive patients who were hospitalized in COVID 19 
referral centers between 1st of March to 30th of April in 2020 were evaluated for MEFV 
gene mutations using ARMS PCR and Sanger sequencing. 
Results: MEFV gene mutations were found in 6 (12%) of the patients. No homozygote or 
compound heterozygote forms were detected. The total mutant allele frequency was 6% 
and carrier rate was 12%. The most common MEFV variant was E148Q which was seen in 
3 (6%) patients. None of the expired patients had MEFV gene mutations. None of the 
MEFV gene mutant patients had FMF symptoms or positive family history of FMF disease. 
Conclusions: Considering the high carrier rate of MEFV gene mutations in the eastern 
Mediterranean region and a significantly lower prevalence of these mutations in COVID 
19 patients, it seems that MEFV gene mutations may have a protective role in incidence of 
the disease. The noted mutations may also have a protective impact on COVID 19 infection 
mortality rate. 
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